SCHEMBL29295705

SCHEMBL29295705

CCCC(NC)c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
CYP2D6 P10635 1/20 0.40
NFKB1 P19838 1/20 0.40
HIF1A Q16665 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
NISCH Q9Y2I1 1/20 0.40
BLM P54132 1/20 0.39
AOC3 Q16853 1/20 0.38
CYP2C19 P33261 1/20 0.36
CASP1 P29466 1/20 0.36
CTSA P10619 3/20 0.35
TAAR1 Q96RJ0 1/20 0.35
HTR1D P28221 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13076103 0.79 ESR1 (0.41) CYP2D6CTSASLC6A2SLC6A4
SCHEMBL11624515 0.79 NISCH (0.53) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL8351658 0.79 HTR2A (0.34) CYP2D6AOC3CYP2C19TAAR1ALDH1A1
SCHEMBL17582487 0.78 CTSA (0.45) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL30878580 0.78 HTT (0.38) CYP2D6AOC3CYP2C19TAAR1ALDH1A1
Hydrochloric Acid SCHEMBL11629925 0.78 NISCH (0.51) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL22244617 0.77 ADRB2 (0.41) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL22162241 0.76 NISCH (0.44) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL9640976 0.75 SLC6A4 (0.50) CYP2C19ALDH1A1SLC6A2SLC6A4
SCHEMBL9284882 0.75 ADRB2 (0.44) ADRB2ADRB1CYP2D6NFKB1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397309-A2 BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2024-07-10 EP disclosed